APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dexlansoprazole Delayed-Release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dexlansoprazole Delayed-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025176 pages

Choose your research edition.

Industry ResearchDexlansoprazole Delayed-Release Capsules Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dexlansoprazole Delayed-Release Capsules Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dexlansoprazole Delayed-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dexlansoprazole Delayed-Release Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dexlansoprazole Delayed-Release Capsules Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dexlansoprazole Delayed-Release Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dexlansoprazole Delayed-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dexlansoprazole Delayed-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dexlansoprazole Delayed-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dexlansoprazole Delayed-Release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dexlansoprazole Delayed-Release Capsules include Takeda Pharmaceuticals, Viatris, TWi Pharmaceuticals and Endo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dexlansoprazole Delayed-Release Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dexlansoprazole Delayed-Release Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dexlansoprazole Delayed-Release Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dexlansoprazole Delayed-Release Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Dexlansoprazole Delayed-Release Capsules Segment by Company

Takeda Pharmaceuticals

Viatris

TWi Pharmaceuticals

Endo

Dexlansoprazole Delayed-Release Capsules Segment by Type

30mg

60mg

Dexlansoprazole Delayed-Release Capsules Segment by Application

Hospital

Clinic

Others

Dexlansoprazole Delayed-Release Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexlansoprazole Delayed-Release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dexlansoprazole Delayed-Release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexlansoprazole Delayed-Release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dexlansoprazole Delayed-Release Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dexlansoprazole Delayed-Release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dexlansoprazole Delayed-Release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dexlansoprazole Delayed-Release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dexlansoprazole Delayed-Release Capsules Industry Trends Table 2. Dexlansoprazole Delayed-Release Capsules Industry Drivers Table 3. Dexlansoprazole Delayed-Release Capsules Industry Opportunities and Challenges Table 4. Dexlansoprazole Delayed-Release Capsules Industry Restraints Table 5. Global Dexlansoprazole Delayed-Release Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dexlansoprazole Delayed-Release Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Manufacturers Table 9. Global Dexlansoprazole Delayed-Release Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dexlansoprazole Delayed-Release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dexlansoprazole Delayed-Release Capsules Manufacturers, Product Type & Application Table 13. Global Dexlansoprazole Delayed-Release Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dexlansoprazole Delayed-Release Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 30mg Table 17. Major Manufacturers of 60mg Table 18. Global Dexlansoprazole Delayed-Release Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2026) Table 22. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2027-2032) Table 23. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Dexlansoprazole Delayed-Release Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2026) Table 35. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2027-2032) Table 36. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2021-2026) Table 44. Global Dexlansoprazole Delayed-Release Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Dexlansoprazole Delayed-Release Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2027-2032) Table 63. Takeda Pharmaceuticals Company Information Table 64. Takeda Pharmaceuticals Business Overview Table 65. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 67. Takeda Pharmaceuticals Recent Development Table 68. Viatris Company Information Table 69. Viatris Business Overview Table 70. Viatris Dexlansoprazole Delayed-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Viatris Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 72. Viatris Recent Development Table 73. TWi Pharmaceuticals Company Information Table 74. TWi Pharmaceuticals Business Overview Table 75. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 77. TWi Pharmaceuticals Recent Development Table 78. Endo Company Information Table 79. Endo Business Overview Table 80. Endo Dexlansoprazole Delayed-Release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Endo Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 82. Endo Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Dexlansoprazole Delayed-Release Capsules Distributors List Table 86. Dexlansoprazole Delayed-Release Capsules Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Dexlansoprazole Delayed-Release Capsules Product Image Figure 2. Global Dexlansoprazole Delayed-Release Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dexlansoprazole Delayed-Release Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Dexlansoprazole Delayed-Release Capsules Sales (2021-2032) & (K Units) Figure 5. Global Dexlansoprazole Delayed-Release Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dexlansoprazole Delayed-Release Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 30mg Image Figure 9. 60mg Image Figure 10. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2021-2032) Figure 39. China Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Dexlansoprazole Delayed-Release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Dexlansoprazole Delayed-Release Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dexlansoprazole Delayed-Release Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dexlansoprazole Delayed-Release Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Viatris
  • TWi Pharmaceuticals
  • Endo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dexlansoprazole Delayed-Release Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dexlansoprazole Delayed-Release Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dexlansoprazole Delayed-Release Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dexlansoprazole Delayed-Release Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dexlansoprazole Delayed-Release Capsules Market Dynamics
  1. 2.1 Dexlansoprazole Delayed-Release Capsules Industry Trends
  2. 2.2 Dexlansoprazole Delayed-Release Capsules Industry Drivers
  3. 2.3 Dexlansoprazole Delayed-Release Capsules Industry Opportunities and Challenges
  4. 2.4 Dexlansoprazole Delayed-Release Capsules Industry Restraints
3 Dexlansoprazole Delayed-Release Capsules Market by Manufacturers
  1. 3.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dexlansoprazole Delayed-Release Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dexlansoprazole Delayed-Release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dexlansoprazole Delayed-Release Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Dexlansoprazole Delayed-Release Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dexlansoprazole Delayed-Release Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dexlansoprazole Delayed-Release Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dexlansoprazole Delayed-Release Capsules Tier 1, Tier 2, and Tier 3
4 Dexlansoprazole Delayed-Release Capsules Market by Type
  1. 4.1 Dexlansoprazole Delayed-Release Capsules Type Introduction
  2. 4.1.1 30mg
  3. 4.1.2 60mg
  4. 4.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Type
  5. 4.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type
  9. 4.3.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2032)
5 Dexlansoprazole Delayed-Release Capsules Market by Application
  1. 5.1 Dexlansoprazole Delayed-Release Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Application
  6. 5.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application
  10. 5.3.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2032)
6 Global Dexlansoprazole Delayed-Release Capsules Sales by Region
  1. 6.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region
  1. 7.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region
  2. 7.1.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032)
  8. 7.2.2 North America Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceuticals
  2. 8.1.1 Takeda Pharmaceuticals Company Information
  3. 8.1.2 Takeda Pharmaceuticals Business Overview
  4. 8.1.3 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
  6. 8.1.5 Takeda Pharmaceuticals Recent Developments
  7. 8.2 Viatris
  8. 8.2.1 Viatris Company Information
  9. 8.2.2 Viatris Business Overview
  10. 8.2.3 Viatris Dexlansoprazole Delayed-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Viatris Dexlansoprazole Delayed-Release Capsules Product Portfolio
  12. 8.2.5 Viatris Recent Developments
  13. 8.3 TWi Pharmaceuticals
  14. 8.3.1 TWi Pharmaceuticals Company Information
  15. 8.3.2 TWi Pharmaceuticals Business Overview
  16. 8.3.3 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
  18. 8.3.5 TWi Pharmaceuticals Recent Developments
  19. 8.4 Endo
  20. 8.4.1 Endo Company Information
  21. 8.4.2 Endo Business Overview
  22. 8.4.3 Endo Dexlansoprazole Delayed-Release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Endo Dexlansoprazole Delayed-Release Capsules Product Portfolio
  24. 8.4.5 Endo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dexlansoprazole Delayed-Release Capsules Value Chain Analysis
  2. 9.1.1 Dexlansoprazole Delayed-Release Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dexlansoprazole Delayed-Release Capsules Production Mode & Process
  6. 9.2 Dexlansoprazole Delayed-Release Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dexlansoprazole Delayed-Release Capsules Distributors
  9. 9.2.3 Dexlansoprazole Delayed-Release Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst